Kinetic Concepts Inc. announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted final regulatory approval for KCI to market and sell its innovative V.A.C.(R) Therapy System in the country. Reimbursement applications have been submitted following regulatory approval. Operational preparations, including employee hiring, are underway for commercial launch at the time of reimbursement approval. KCI anticipates reimbursement approval in the first half of 2010.

Kinetic Concepts Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported net earnings were $64,569,000 or $0.92 per basic share and $0.91 per diluted share on total revenue of $504,397,000 against net earnings were $53,911,000 or $0.75 per basic and diluted share on total revenue of $503,299,000 for the same period a year ago. Operating earnings were $114,235,000 compared to $112,872,000 for the same period a year ago. Earnings before income taxes were $91,848,000 compared to $80,511,000 for the same period a year ago. Adjusted diluted EPS was $1.08. For the nine months, the company reported net earnings were $162,371,000 or $2.32 per basic share and $2.31 per diluted share on total revenue of $1,465,827,000 against net earnings were $117,053,000 or $1.63 per basic share and $1.62 per diluted share on total revenue of $1,385,439,000 for the same period a year ago. Operating earnings were $319,226,000 compared to $255,043,000 for the same period a year ago. Earnings before income taxes were $235,527,000 compared to $208,238,000 for the same period a year ago. Net cash provided by operating activities of $272,483,000 compared to $271,755,000 for the same period a year ago. Additions to property, plant and equipment of $66,019,000 compared to $83,748,000 for the same period a year ago. Adjusted diluted EPS was $2.89. The company reaffirmed earnings guidance for the full year 2009. For the period, the company expects Diluted EPS to be in the range of $3.19 to $3.34. Total revenue to be in the range of $1,950 million to $2,000 million. Adjusted Diluted EPS to be in the range of $3.95 to $4.10. The revenue guidance reflects company's expectation of continued capital constraints in the hospital setting, resulting in a double-digit decline in TSS revenue, combined with slower international V.A.C. Therapy revenue growth due to additional competitive and economic factors.

Kinetic Concepts Inc. reported cash flow results for the nine months of 2009. For the period, the company's operating cash flow less net capital expenditures was $208.4 million, an increase of 18%, from the year ago period.